1. HBW Insight
  2. >>Wellness
  3. >>Policy & Regulation

Bayer Hit With Fine For Ads Targeting Kids In Hungary

 
• By Tom Gallen

Bayer broke rules on advertising directly to children in promotions for its Supradyn supplement, according to Hungary's competition authority, which imposed a fine on the company for the second time in 12 months. 

Sick_Girl
• Source: Shutterstock

Hungary’s competition authority, the GVH, has slapped Bayer AG with a fine after ruling the consumer health player broke the rules on advertising to children. It is the second time in 12 months Bayer’s Hungarian operation has been hit with a financial penalty for its marketing practices.

Bayer has been ordered to pay HUF7.0m ($23,462) by the GVH, which judged television and print ads for the Supradyn...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Legal

More from Policy & Regulation

US FDA Clarifies Success For An NDI Notification Fits Only The Notifier’s Ingredient

Along with two instructional videos, FDA provides fact sheet detailing common problems with NDINs while supplement industry awaits guidance on two hurdles for clearing the NDIN process, providing identity information and evidence of safety for ingredients.

Price To Resolve US Hemp Dilemma Too High In House Appropriators’ FY 2026 FDA Spending Bill

 
• By Malcolm Spicer

Provisions in bill approved by Agriculture, Rural Development, FDA and Related Agencies Subcommittee aren’t likely to pass largely because they set a price too high for delta-8 THC and other ingredients to meet the definition of hemp as a de-scheduled substance.

AESGP Annual Meeting: Harmonizing EU VMS Max Levels Could Cost Sector Over €200m

 
• By David Ridley

Limited capacity and a two-to-three year timescale for reformulation could mean that many VMS supplements disappear from the market, warns EPPA partner Alexandra Bocquillion, speaking at the AESGP Annual Meeting in Warsaw, Poland.